InflaRx (IFRX) Net Margin (2023 - 2025)
InflaRx's (IFRX) quarterly Net Margin came in at 2506775885.36% in Q4 2025, down 249656103714.0% year-on-year from N/an in Q4 2024, and down 31297483.0% quarter-over-quarter from 8009.49% in Q3 2025.
InflaRx (IFRX) Net Margin (2023 - 2025) Analysis & Trends
InflaRx has disclosed Net Margin across 3 years of filings, most recently posting 2506775885.36% for Q4 2025.
- Net Margin for Q4 2025 came in at 2506775885.36%, down 249656103714.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 1888695506.56% (up 188869284992.0% YoY), and the FY2025 annual result was 155582.08%, down 12779712.0% from the prior year.
- Net Margin came in at 2506775885.36% for Q4 2025 at InflaRx, down from 8009.49% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 8009.49% in Q3 2025 to a low of 2506775885.36% in Q4 2025.
- The 3-year median for Net Margin is 34706.8% (2025), against an average of 279767209.98%.
- Peak annual rise in Net Margin reached 18429372 bps in 2025, while the deepest fall reached 2000000000 bps in 2025.
- InflaRx's Net Margin stood at 584310.54% in 2023, then sank by 1648 bps to 10214848.22% in 2024, then tumbled by 24441 bps to 2506775885.36% in 2025.
- The last three Net Margin figures came in at 2506775885.36% (Q4 2025), 8009.49% (Q3 2025), and 30175.11% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 0.82% |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 34.53% |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | InflaRx | 764.68 Mn | 764.68 Mn | 10,877.40 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2,506,775,885.36% |
| Sep 30, 2025 | -8,009.49% |
| Jun 30, 2025 | -30,175.11% |
| Mar 31, 2025 | -34,706.80% |
| Dec 31, 2024 | -10,214,848.22% |
| Sep 30, 2024 | -10,363.94% |
| Jun 30, 2024 | -214,468.82% |
| Mar 31, 2024 | -32,121.52% |
| Dec 31, 2023 | -584,310.54% |